Literature DB >> 7398752

Effectiveness and pharmacokinetics of indomethacin in premature newborns with patent ductus arteriosus.

P Vert, G Bianchetti, F Marchal, P Monin, P L Morselli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7398752     DOI： 10.1007/bf00561483

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  14 in total

1.  Failure of indomethacin therapy to induce closure of patent ductus arteriosus in premature infants with respiratory distress syndrome.

Authors:  W A Neal; J M Kyle; M D Mullett
Journal:  J Pediatr       Date:  1977-10       Impact factor: 4.406

Review 2.  The patent ductus arteriosus.

Authors:  W F Friedman; K M Fitzpatrick; T A Merritt; B H Feldman
Journal:  Clin Perinatol       Date:  1978-09       Impact factor: 3.430

3.  The contribution of PDA in the neonate with severe RDS.

Authors:  J Jacob; L Gluck; T DiSessa; D Edwards; M Kulovich; J Kurlinski; T A Merritt; W F Friedman
Journal:  J Pediatr       Date:  1980-01       Impact factor: 4.406

4.  Significance of the prostaglandin system to the control of muscle tone of the ductus arteriosus.

Authors:  F Coceani; P M Olley; I Bishai; E Bodach; E P White
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1978

5.  Age-dependent closure of the patent ductus arteriosus by indomethacin.

Authors:  J S McCarthy; L G Zies; H Gelband
Journal:  Pediatrics       Date:  1978-11       Impact factor: 7.124

6.  Pharmacologic closure of patent ductus arteriosus in the premature infant.

Authors:  W F Friedman; M J Hirschklau; M P Printz; P T Pitlick; S E Kirkpatrick
Journal:  N Engl J Med       Date:  1976-09-02       Impact factor: 91.245

7.  Gestational age and indomethacin elimination in the neonate.

Authors:  M A Evans; R Bhat; D Vidyasagar; M Vadapalli; E Fisher; A Hastreiter
Journal:  Clin Pharmacol Ther       Date:  1979-12       Impact factor: 6.875

8.  Disposition of indomethacin in preterm infants.

Authors:  R Bhat; D Vidyasagar; M Vadapalli; C Whalley; E Fisher; A Hastreiter; M Evans
Journal:  J Pediatr       Date:  1979-08       Impact factor: 4.406

9.  Pharmacokinetics of indomethacin in the premature infant.

Authors:  G Bianchetti; P Monin; F Marchal; C Dubruc; M J Boutroy; P L Morselli; P Vert
Journal:  Dev Pharmacol Ther       Date:  1980

10.  Displacement of bilirubin from albumin by indomethacin.

Authors:  L F Rasmussen; C E Ahlfors; R P Wennberg
Journal:  J Clin Pharmacol       Date:  1978-10       Impact factor: 3.126
View more
  18 in total

1.  Effect of indomethacin on binding of bilirubin to albumin.

Authors:  B C Lam; H N Wong; C Y Yeung
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

2.  Prolonged low dose indomethacin for persistent ductus arteriosus of prematurity.

Authors:  J M Rennie; R W Cooke
Journal:  Arch Dis Child       Date:  1991-01       Impact factor: 3.791

Review 3.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part II.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 4.  Clinical pharmacology of the perinatal period and early infancy.

Authors:  P L Morselli
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

Review 5.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

6.  Tolerance of intravenous indomethacin treatment for premature infants with patent ductus arteriosus.

Authors:  M Walters
Journal:  BMJ       Date:  1988-09-24

7.  Clinical Pharmacokinetics of indomethacin.

Authors:  L Helleberg
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

8.  Intravenous indometacin in preterm infants with symptomatic patent ductus arteriosus. A population pharmacokinetic study.

Authors:  J M Smyth; P S Collier; M Darwish; J S Millership; H L Halliday; S Petersen; J C McElnay
Journal:  Br J Clin Pharmacol       Date:  2004-09       Impact factor: 4.335

9.  Variability of serum indomethacin concentrations after oral and intravenous administration to preterm infants.

Authors:  R Mrongovius; H Imbeck; L Wille; H Müller; H W Seyberth
Journal:  Eur J Pediatr       Date:  1982-03       Impact factor: 3.183

10.  Excretion of indomethacin in breast milk.

Authors:  T H Lebedevs; R E Wojnar-Horton; P Yapp; M J Roberts; L J Dusci; L P Hackett; K F Ilett
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.